227 related articles for article (PubMed ID: 33955457)
1. Effective Host-Directed Therapy for Tuberculosis by Depletion of Myeloid-Derived Suppressor Cells and Related Cells Using a Diphtheria Toxin Fusion Protein.
Parveen S; Lun S; Urbanowski ME; Cardin M; Shen J; Murphy JR; Bishai WR
J Infect Dis; 2021 Dec; 224(11):1962-1972. PubMed ID: 33955457
[TBL] [Abstract][Full Text] [Related]
2. Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
Gupta S; Cheung L; Pokkali S; Winglee K; Guo H; Murphy JR; Bishai WR
J Infect Dis; 2017 Jun; 215(12):1883-1887. PubMed ID: 28863467
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.
Parveen S; Siddharth S; Cheung LS; Kumar A; Shen J; Murphy JR; Sharma D; Bishai WR
Mol Oncol; 2021 May; 15(5):1330-1344. PubMed ID: 33682324
[TBL] [Abstract][Full Text] [Related]
4. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
[TBL] [Abstract][Full Text] [Related]
6. Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis.
Leukes VN; Dorhoi A; Malherbe ST; Maasdorp E; Khoury J; McAnda S; Walzl G; du Plessis N
Cell Immunol; 2021 Jun; 364():104359. PubMed ID: 33865151
[TBL] [Abstract][Full Text] [Related]
7. Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors.
Jøntvedt Jørgensen M; Jenum S; Tonby K; Mortensen R; Walzl G; Du Plessis N; Dyrhol-Riise AM
J Leukoc Biol; 2021 Jul; 110(1):177-186. PubMed ID: 33155730
[TBL] [Abstract][Full Text] [Related]
8. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.
Magcwebeba T; Dorhoi A; du Plessis N
Front Immunol; 2019; 10():917. PubMed ID: 31114578
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis.
Leukes V; Walzl G; du Plessis N
Front Immunol; 2020; 11():451. PubMed ID: 32269568
[TBL] [Abstract][Full Text] [Related]
10. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
Namdev P; Patel S; Sparling B; Garg A
Front Immunol; 2021; 12():647019. PubMed ID: 33995365
[TBL] [Abstract][Full Text] [Related]
11. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.
Dorhoi A; Kotzé LA; Berzofsky JA; Sui Y; Gabrilovich DI; Garg A; Hafner R; Khader SA; Schaible UE; Kaufmann SH; Walzl G; Lutz MB; Mahon RN; Ostrand-Rosenberg S; Bishai W; du Plessis N
J Clin Invest; 2020 Jun; 130(6):2789-2799. PubMed ID: 32420917
[TBL] [Abstract][Full Text] [Related]
12. Distinct Role of CD11b
Wu SY; Chiang CS
Cells; 2019 Dec; 9(1):. PubMed ID: 31878276
[TBL] [Abstract][Full Text] [Related]
13. Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice.
Hurez V; Daniel BJ; Sun L; Liu AJ; Ludwig SM; Kious MJ; Thibodeaux SR; Pandeswara S; Murthy K; Livi CB; Wall S; Brumlik MJ; Shin T; Zhang B; Curiel TJ
Cancer Res; 2012 Apr; 72(8):2089-99. PubMed ID: 22496463
[TBL] [Abstract][Full Text] [Related]
14. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
Guo S; Smeltz RB; Nanajian A; Heller R
Front Immunol; 2020; 11():614667. PubMed ID: 33628206
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells.
John V; Kotze LA; Ribechini E; Walzl G; Du Plessis N; Lutz MB
Front Immunol; 2019; 10():2826. PubMed ID: 31849990
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure.
Zhou L; Miao K; Yin B; Li H; Fan J; Zhu Y; Ba H; Zhang Z; Chen F; Wang J; Zhao C; Li Z; Wang DW
Circulation; 2018 Jul; 138(2):181-197. PubMed ID: 29437117
[TBL] [Abstract][Full Text] [Related]
17. Human Monocytic Suppressive Cells Promote Replication of
Agrawal N; Streata I; Pei G; Weiner J; Kotze L; Bandermann S; Lozza L; Walzl G; du Plessis N; Ioana M; Kaufmann SHE; Dorhoi A
Front Immunol; 2018; 9():2417. PubMed ID: 30405617
[TBL] [Abstract][Full Text] [Related]
18. Harmful Effects of Granulocytic Myeloid-Derived Suppressor Cells on Tuberculosis Caused by Hypervirulent Mycobacteria.
Barbosa Bomfim CC; Pinheiro Amaral E; Santiago-Carvalho I; Almeida Santos G; Machado Salles É; Hastreiter AA; Silva do Nascimento R; Almeida FM; Lopes Biá Ventura Simão T; Linhares Rezende A; Hiroyuki Hirata M; Ambrósio Fock R; Álvarez JM; Lasunskaia EB; D'Império Lima MR
J Infect Dis; 2021 Feb; 223(3):494-507. PubMed ID: 33206171
[TBL] [Abstract][Full Text] [Related]
19. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
Xing YF; Cai RM; Lin Q; Ye QJ; Ren JH; Yin LH; Li X
Kidney Int; 2017 May; 91(5):1236-1242. PubMed ID: 28215666
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
